Holden Leads Blog
Data, outreach strategies, and market intelligence for cannabis B2B professionals.
For years, cannabis operators have been paying more in federal taxes than almost any other industry in America — not because they're unusually profitable, but because of a single line in the tax code that forbids businesses trafficking in Schedule I controlled substances from deducting normal operating expenses.
Read more →The data from this year's holiday week, combined with a handful of notable launches that landed just before or during it, paints a picture of an industry that is maturing in real time: less novelty, more intentionality, and a consumer base that increasingly knows exactly what it wants.
Read more →Two product stories dominated the cannabis space this week, and they couldn't be more different. One involves a Canadian LP crafting ultra-premium, liquid diamond-infused flower for consumers who have, in the company's own framing, already exhausted everything else. The other involves a hemp-derived CBD company positioning its products for elderly Medicare beneficiaries managing chronic conditions. Taken separately, they're interesting brand launches. Taken together, they reveal something meanin
Read more →A landmark study published this week is now forcing a more honest conversation about what the science actually says.
Read more →The reallity of rescheduling is not what it seems, and will not be as fast as it sounds.
Read more →